{"entity":{"type":"insider","cik":"0001986112","url":"/insider/0001986112","json_url":"/insider/0001986112.json","name":"Aminov Erez","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":4,"first":"2024-05-22","last":"2026-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Aminov Erez","source":"filing","n_filings":4,"first_seen":"2024-05-22","last_seen":"2026-02-17"}],"transactions":[{"id":5946917,"accession":"0001493152-26-007226","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001493152-26-007226","line_url":"/filing/0001493152-26-007226#line-5","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":"0001986112","owner_name":"Aminov Erez","owner_display_name":"Aminov Erez","owner_url":"/insider/0001986112","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":613595.0,"shares_display":"613,595","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":1294685.45,"total_display":"1,294,685.45","total_whole":"1,294,685","shares_owned_after":3592666.0,"shares_owned_after_display":"3,592,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2026-02-17","scope":"insider"},{"id":2692861,"accession":"0001493152-24-047998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-047998","line_url":"/filing/0001493152-24-047998#line-2","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":"0001986112","owner_name":"Aminov Erez","owner_display_name":"Aminov Erez","owner_url":"/insider/0001986112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44590.0,"shares_display":"44,590","price_per_share":1.27,"price_display":"1.27","price_state":"stated","total_value":56629.3,"total_display":"56,629.30","total_whole":"56,629","shares_owned_after":1061200.0,"shares_owned_after_display":"1,061,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-27","scope":"insider"},{"id":2692854,"accession":"0001493152-24-047998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-047998","line_url":"/filing/0001493152-24-047998#line-1","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":"0001986112","owner_name":"Aminov Erez","owner_display_name":"Aminov Erez","owner_url":"/insider/0001986112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55410.0,"shares_display":"55,410","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":77019.9,"total_display":"77,019.90","total_whole":"77,020","shares_owned_after":1105790.0,"shares_owned_after_display":"1,105,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-27","scope":"insider"},{"id":4782996,"accession":"0001493152-25-004853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-25-004853","line_url":"/filing/0001493152-25-004853","is_derivative":false,"issuer_cik":"0001971532","issuer_name":"Telomir Pharmaceuticals, Inc.","issuer_ticker":"TELO","issuer_name_source":null,"issuer_url":"/issuer/0001971532","owner_cik":"0001986112","owner_name":"Aminov Erez","owner_display_name":"Aminov Erez","owner_url":"/insider/0001986112","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.105,"price_display":"6.10","price_state":"stated","total_value":2442.0,"total_display":"2,442.00","total_whole":"2,442","shares_owned_after":29600.0,"shares_owned_after_display":"29,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2025-02-04","scope":"insider","n_lines":2},{"id":2055801,"accession":"0001493152-24-021069","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001493152-24-021069","line_url":"/filing/0001493152-24-021069","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":"0001986112","owner_name":"Aminov Erez","owner_display_name":"Aminov Erez","owner_url":"/insider/0001986112","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8700.0,"shares_display":"8,700","price_per_share":0.9397701149425287,"price_display":"0.94","price_state":"stated","total_value":8176.0,"total_display":"8,176.00","total_whole":"8,176","shares_owned_after":375500.0,"shares_owned_after_display":"375,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001904286","name":"MIRA PHARMACEUTICALS, INC.","url":"/issuer/0001904286","role":"Director, Officer (CEO and Chairman)","n_filings":3,"first_seen":"2024-05-22","last_seen":"2026-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001971532","name":"Telomir Pharmaceuticals, Inc.","url":"/issuer/0001971532","role":"Director, Officer (CEO and Chairman)","n_filings":1,"first_seen":"2025-02-04","last_seen":"2025-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001986112","retrieved_at":"2026-08-26T17:28:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}